Harbour Investments’s BeOne Medicines Ltd ONC Stock Holding History

Harbour Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Hold	42	–	–	﹤0.01%	3262
2026 Q1	$12.5K	Sell	42 -5	-11%	-$1.62K	﹤0.01%	3142
2025 Q4	$14.3K	Hold	47	–	–	﹤0.01%	2576
2025 Q3	$16K	Hold	47	–	–	﹤0.01%	2464
2025 Q2	$11.4K	Hold	47	–	–	﹤0.01%	2505
2025 Q1	$12.8K	Hold	47	–	–	﹤0.01%	2397
2024 Q4	$8.68K	Hold	47	–	–	﹤0.01%	2512
2024 Q3	$10.6K	Hold	47	–	–	﹤0.01%	2331
2024 Q2	$6.71K	Hold	47	–	–	﹤0.01%	2412
2024 Q1	$7.35K	Buy	47 +5	+12%	+$805	﹤0.01%	2336
2023 Q4	$7.58K	Hold	42	–	–	﹤0.01%	2257
2023 Q3	$7.55K	Sell	42 -1	-2%	-$198	﹤0.01%	2138
2023 Q2	$7.67K	Hold	43	–	–	﹤0.01%	2145
2023 Q1	$9.27K	Buy	43 +11	+34%	+$2.64K	﹤0.01%	2033
2022 Q4	$7.04K	Buy	32 +3	+10%	+$550	﹤0.01%	2102
2022 Q3	$5K	Hold	29	–	–	﹤0.01%	2212
2022 Q2	$5K	Buy	+29	New	+$4.53K	﹤0.01%	2212
2021 Q4	$7K	Buy	27 +7	+35%	+$2.36K	﹤0.01%	2078
2021 Q3	$7K	Buy	20 +14	+233%	+$4.58K	﹤0.01%	2862
2021 Q2	$2K	Buy	+6	New	+$1.99K	﹤0.01%	3450

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Harbour Investments's ONC Position: Q2 2026 in Review

Harbour Investments held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 42 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3262.

Harbour Investments first reported a position in ONC in Q2 2021 and has held it in 20 quarters since. The position peaked at $16K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Harbour Investments held 42 shares of BeOne Medicines Ltd worth $12K as of Q2 2026.
Harbour Investments left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3262 holding.
Harbour Investments first reported a position in BeOne Medicines Ltd in Q2 2021 and has held it in 20 quarters since.
Harbour Investments's BeOne Medicines Ltd position peaked at $16K in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.